Nitric oxide-containing neurons in long-term grafts in a rat model of Parkinson's disease

Cell Transplantation

Volumn 16, Issue 5, 2007, Pages 449-459

  Rajakumar, B ^a   Flumerfelt, B A ^a   Hrycyshyn, A W ^a   Rajakumar, N ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Dopamine; NADPH diaphorase; Neural tissue transplantation; Nitric oxide synthase; Striatum; Ventral mesencephalon

Indexed keywords

7 NITROINDAZOLE; METHAMPHETAMINE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SOMATOSTATIN; 7-NITROINDAZOLE; CHOLINE; INDAZOLE DERIVATIVE; NITRIC OXIDE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN GRAFT; CELL STRUCTURE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; IMMUNOHISTOCHEMISTRY; INTERPEDUNCULAR NUCLEUS; MESENCEPHALON; NONHUMAN; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; ANIMAL; BRAIN TRANSPLANTATION; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; METABOLISM; NEOSTRIATUM; NERVE CELL; PATHOLOGY; PREGNANCY; ROTATION; SPRAGUE DAWLEY RAT; TIME;

ANIMALIA; RATTUS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN TISSUE TRANSPLANTATION; CHOLINE; DISEASE MODELS, ANIMAL; FEMALE; INDAZOLES; METHAMPHETAMINE; NADPH DEHYDROGENASE; NEOSTRIATUM; NEURONS; NITRIC OXIDE; PARKINSON DISEASE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; SOMATOSTATIN; TIME FACTORS; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 34548384274     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000007783464975     Document Type: Article

References (55)

1. Abu-Soud, H. M.; Stuehr, D. J. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc. Nat. Acad. Sci. USA 90:10769-10772; 1993.
2. Annett, L. E.; Martel, F. L.; Rogers, D. C.; Ridley, R. M.; Baker, H. F.; Dunnett, S. B. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 125:228-246; 1994.
3. Babbedge, R. C.; Bland-Ward, P. A.; Hart, S. L.; Moore, P. K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitroindazole and related substituted indazoles. Br. J. Pharmacol. 110:225-228; 1993.
4. Barthwal, M. K.; Srivastava, N.; Dikshit, M. Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat. Redox Report 6:297-302; 2001.
5. Beal, M. F. Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Ann. Neurol. 44:S110-S114; 1998.
6. Beal, M. F.; Kowall, N. W.; Swartz, K. J.; Ferrante, R. J.; Martin, J. B. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse 3:38-47; 1989.
7. Beckman, J. S.; Beckman, T. W.; Chen, J.; Marshall, P. A.; Freeman, B. A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Nat. Acad. Sci. USA 87:1620-1624; 1990.
8. Björklund, A.; Lindvall, O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3:537-544; 2000.
9. Björklund, A.; Stenevi, U.; Schmidt, R. H.; Dunnett, S. B.; Gage, F. H. Intracerebral grafting of neuronal cell suspensions: 1. Introduction and general methods of preparation. Acta Physiol. Scand. (Suppl.) 522:1-7; 1983.
10. Brundin, P.; Isacson, O.; Björklund, A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331:251-259; 1985.
11. Borlongan, C. V. Transplantation therapy for Parkinson's disease. Expert Opin. Invest. Drugs 9:2319-2330; 2000.
12. Borlongan, C. V.; Sanberg, P. R.; Freeman, T. B. Neural transplantation for neurodegenerative disorders. Lancet 353(Suppl. 1):S129-S130; 1999.
13. Cenci, M. A.; Campbell, K.; Björklund, A. Neuropeptide messenger RNA expression in the 6-hydroxydopaminelesioned rat striatum reinnervated by fetal dopaminergic transplants: Differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels. Neuroscience 57:275-296; 1993.
14. Chapman, V.; Buritova, J.; Honore, P.; Besson, J.-M. 7-Nitro-indazole, a selective inhibitor of neuronal nitric oxide synthase, reduces formalin evoked c-Fos expression in dorsal horn neurons of the rat spinal cord. Brain Res. 697:258-261; 1995.
15. Chung, K. K.; Dawson, T. M.; Dawson, V. L. Nitric oxide, S-nitrosylation and neurodegeneration. Cell. Mol. Biol. 51:247-254; 2005.
16. Chung, K. K.; Thomas, B.; Li, X.; Pletnikova, O.; Troncoso, J. C.; Marsh, L.; Dawson, V. L.; Dawson, T. M. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304:1328-1331; 2004.
17. 3H]dopamine uptake. Exp. Brain Res. 77:552-568; 1989.
18. Drucker-Colin, R.; Verdugo-Diaz, L. Cell transplantation for Parkinson's disease: Present status. Cell. Mol. Neurobiol. 24:301-316; 2004.
19. Duncan, A. J.; Heales, S. J. Nitric oxide and neurological disorders. Mol. Aspects Med. 26:67-96; 2005.
20. Dunnett, S. B.; Björklund, A. Basic neural transplantation techniques. I. Dissociated cell suspension grafts of embryonic ventral mesencephalon in the adult rat brain. Brain Res. Protocols 1:91-99; 1997.
21. Ebadi, M.; Sharma, S. K. Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. Antioxidants Redox Signaling 5:319-335; 2003.
22. Freed, C. R.; Greene, P. E.; Breeze, R. E.; Tsai, W. Y.; DuMouchel, W.; Kao, R.; Dillon, S.; Winfield, H.; Culver, S.; Trojanowski, J. Q.; Eidelberg, D.; Fahn, S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344:710-719; 2001.
23. Freeman, T. B.; Olanow, C. W.; Hauser, R. A.; Nauert, G. M.; Smith, D. A.; Borlongan, C. V.; Sanberg, P. R.; Holt, D. A.; Kordower, J. H.; Vingerhoets, F. J. Bilateral fetal nigral transplantation into the post-commissural putamen as a treatment of Parkinson's disease: Six months follow-up. Ann. Neurol. 38:379-388; 1995.
24. Fricker-Gates, R. A.; Dunnett, S. B. Rewiring the parkinsonian brain. Nat. Med. 8:105-106; 2002.
25. Garthwaite, J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trend Neurosci. 14:60-67; 1991.
26. Gates, M. A.; Olsson, M.; Bjerregaard, K.; Björklund, A. Region-specific migration of embryonic glia grafted to the neonatal brain. Neuroscience 84:1013-1023; 1998.
27. Greene, P. E.; Fahn, S. Status of fetal tissue transplantation for the treatment of advanced Parkinson's disease. Neurosurg. Focus 13:1-9; 2002.
28. Guevara-Guzman, R.; Emson, P. C.; Kendrick, K. M. Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem. 62:807-810; 1994.
29. Hagell, P.; Cenci, M. A. Dyskinesias and dopamine cell replacement in Parkinson's disease: A clinical perspective. Brain Res. Bull. 68:4-15; 2005.
30. Hunot, S.; Boissiere, F.; Faucheux, B.; Brugg, B.; Mouatt-Prigent, A.; Agid, Y.; Hirsch, E. C. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72:355-363; 1996.
31. Jenner, P.; Olanow, C. W. Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders. In: Olanow, C. W.; Jenner, P.; Youdim, M., eds. Neurodegeneration and neuroprotection in Parkinson's disease. London: Academic Press; 1996:24-45.
32. Kirik, D.; Björklund, A. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results. Brain 128:1478-1479; 2005.
33. Kordower, J. H.; Freeman, T. B.; Snow, B. J.; Vingerhoets, F. J. G.; Mufson, E. J.; Sanberg, P. R.; Hauser, R. A.; Smith, D. A.; Nauert, G. M.; Perl, D. P.; Olanow, C. W. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1118-1124; 1995.
34. Kordower, J. H.; Freeman, T. B.; Chen, E. Y.; Mufson, E. J.; Sanberg, P. R.; Hauser, R. A.; Snow, B. J.; Olanow, C. W. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord. 13:383-393; 1998.
35. Lindvall, O. Clinical application of neuronal grafts in Parkinson's disease. J. Neurol. Suppl. 242:S54-56; 1994.
36. Lindvall, O. Cerebral implantation in movement disorders: State of the art. Mov. Disord. 14:201-205; 1999.
37. Lindvall, O.; Hagell, P. Role of cell therapy in Parkinson's disease. Neurosurg. Focus 13:1-9; 2002.
38. MacKenzie, G. M.; Rose, S.; Bland-Ward, P. A.; Moore, P. K.; Jenner, P.; Marsden, C. D. Time course of inhibition of brain nitric oxide synthase by 7-nitroindazole. Neuroreport 5:1993-1996; 1994.
39. Mendez, I.; Elisevich, K.; Naus, C.; Flumerfelt, B. Restoration of nigrostriatal circuitry, striatal mRNA expression, and motor asymmetry following embryonic substantia nigra grafts. Clin. Neurosurg. 38:180-209; 1992.
40. Mendez, K. E. Effects of neurotoxin and neural grafting on the blood-brain barrier. M.Sc. thesis. University of Western Ontario, London; 1995.
41. 3H]dopamine release from dissociated cell cultures of rat ventral mesencephalon. J. Neurochem. 52:1300-1310; 1989.
42. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. London: Academic Press; 1987.
43. Rajakumar, N.; Flumerfelt, B. A.; Rajakumar, B. NADPH-d-containing neurons in long-term fetal nigral grafts in an animal model of Parkinson's disease. 6th International Conference in Neural Transplantation, San Diego, USA; 1997.
44. Rajakumar, N.; Rushlow, W.; Rajakumar, B.; Naus, C. G.; Stoessl, A. J.; Flumerfelt, B. A. Effects of graft-derived dopaminergic innervation on the target neurons of patch and matrix compartments of the striatum. Neuroscience 76:1173-1185; 1997.
45. Rose, S.; MacKenzie, G. M.; Jenner, P. Nitric oxide and basal ganglia degeneration. Adv. Neurol. 80:247-257; 1999.
46. Rushlow, W.; Flumerfelt, B. A.; Naus, C. C. Colocalization of somatostatin, neuropeptide Y, and NADPH-diaphorase in the caudate-putamen of the rat. J. Comp. Neurol. 351:499-508; 1995.
47. Siesjo, B. K.; Bengtsson, F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: A unifying hypothesis. J. Cereb. Blood Flow Metab. 9:127-140; 1989.
48. Tabbal, S.; Fahn, S.; Frucht, S. Fetal tissue transplantation in Parkinson's disease. Curr. Opin. Neurol. 11:341-349; 1998.
49. Thompson, L.; Barraud, P.; Andersson, E.; Kirik, D.; Björklund, A. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J. Neurosci. 25:6467-6477; 2005.
50. Uemura, Y.; Kowall, N. W.; Beal, M. F. Selective sparing of NADPH-diaphorase-somatostatin-neuropeptideY neurons in ischemic gerbil striatum. Ann. Neurol. 27:620-625; 1990.
51. Ungerstedt, U.; Arbuthnott, G. W. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:485-493; 1970.
52. Vincent, S. R.; Satoh, K.; Armstrong, D. M.; Fibiger, H. C. NADPH-diaphorase: A selective histochemical marker for the cholinergic neurons of the pontine reticular formation. Neurosci. Lett. 43:31-36; 1983.
53. Vincent, S. R.; Johansson, O.; Hokfelt, T.; Skirboll, L.; Eide, R. P.; Terenius, L.; Kimmel, J.; Goldstein, M. NADPH-diaphorase: A selective histochemical marker for striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities. J. Comp. Neurol. 217:252-263; 1983.
54. Wenning, G. K.; Odin, P.; Morrish, P. K.; Rehncrona, S.; Widner, H.; Brundin, P.; Rothwell, J. C.; Brown, R.; Gustavii, B.; Hagell, P.; Jahanshahi, M.; Sawle, G.; Björklund, A.; Brooks, D. J.; Marsden, C. D.; Quinn, N. P.; Lindvall, O. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42:95-107; 1997.
55. Wood, J.; Garthwaite, J. Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties. Neuropharmacology 33:1235-1244; 1994.